14Dec
Financial Daily Dose 12.14.2020 | Top Story: AstraZeneca Acquires Alexion in $39 Billion Push into Immunology
Drugmaker AstraZeneca agreed on Saturday to buy biopharma company Alexion for $39 billion in cash and stock. In the deal—the “biggest by a health care company this year”—will help AstraZeneca expand into the immunology sector....
By:
Robins Kaplan LLP
Related
A federal court in Sacramento explained last week its rationale for temporarily barring the State of...
Read More >
Given that the gig economy is a relatively recent phenomenon, the industry has not yet experienced s...
Read More >
The UK Parliament recently introduced a right to two weeks’ paid bereavement leave for employees wh...
Read More >
Medical marijuana has finally arrived. Over 53,000 Ohio residents have applied for and received medi...
Read More >
Since the release of our recent article “Poison Pills, NOL Poison Pills and the COVID-19 Pandemic”...
Read More >
The coronavirus (COVID-19) is infecting the construction industry with multiple crises simultaneousl...
Read More >